aqst stock forecast zacks

Sunday, November 6, 2022 Edit

46019 Upside Based on 6 Wall Street analysts offering 12 month price targets for Aquestive Therapeutics in the last 3 months. AQST stock quote history news and other vital information to help you with your stock trading and investing.

Aqst

Get the latest Full Company Report for Aquestive Therapeutics from Zacks Investment Research.

. Aquestive Therapeutics AQST Quick Quote AQST - Free Report came out with a quarterly loss of 023 per share versus the Zacks Consensus Estimate of a loss of 030. 5 equities research analysts have issued twelve-month price targets for Aquestive Therapeutics stock. Stock price gained 148 on the last trading day Friday 4th Nov 2022 rising from 086 to.

The Aquestive Therapeutics Inc. The 7 analysts offering 12-month price forecasts for Aquestive Therapeutics Inc have a median target of 500 with a high estimate of 950 and a low estimate. Zacks tracks individual sell-side analyst estimates and creates a.

Aquestive Therapeutics stock forecast 2022 - 2025 - 2030 with analysis. Aquestive Therapeutics - Full Company Report. Based on short-term price targets offered by three analysts the average price target for Aquestive Therapeutics comes to 633.

All of those stocks are classified into three groups. If the PS ratio is 1 that means youre paying 1 for. AQST Quick Quote AQST.

25 Aristocrats 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did. Sector M Industry and X Industry. After the PE ratio its one of the most common valuation metrics.

AQST Stock Price Prediction. Aquestive Therapeutics stock stood at 10900000333786 on 2022-09-23. Sell candidate since 2022-10-10 Loss -1422 PDF.

Their AQST share price forecasts range from 500 to 1700. The lowest target is 303 and the. There are 17 Sectors 60 different M Industries and.

Find the latest Aquestive Therapeutics Inc. The forecasts range from a. Get the latest Zacks research report on AQST FREE.

According to latest technical analysis. The average price target. According to 13 analysts the average rating for AQST stock is Buy The 12-month stock price forecast is 648 which is an increase of 67143 from the.

Aquestive Therapeutics AQST delivered. The Price and Consensus chart displays the companys stock price along with the consensus estimate. Aquestive Therapeutics AQST Reports Q4 Loss Tops Revenue Estimates.

Rooms Rankings Earnings Newsletters. Price Target. Real-time trade and investing ideas on Aquestive Therapeutics Inc AQST from the largest community of traders and investors.

The Zacks database contains over 10000 stocks. Analyst AQST forecast. According to 13 stock analysts the average 12-month stock price forecast for AQST stock is 648 which predicts an increase of 64057.

The Price to Sales ratio or PS is calculated as price divided by sales. By Zacks Equity Research Published on March 092021. Get the latest stock and industry comparisons from Zacks Investment Research.

Aqst